The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States

BACKGROUND: The US National HIV/AIDS Strategy (NHAS) aims for 72% (90% diagnosed times 80% of those virally suppressed) viral suppression among persons with human immunodeficiency virus (HIV) by 2020. We examined the clinical and economic impact of reaching this target, in the general US population...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Borre, Ethan D, Hyle, Emily P, Paltiel, A David, Neilan, Anne M, Sax, Paul E, Freedberg, Kenneth A, Weinstein, Milton C, Walensky, Rochelle P
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853503/
https://ncbi.nlm.nih.gov/pubmed/29029344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix349
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars